IL162150A0 - Use of anastrozole for the treatment of post-menopausal women having early breast cancer - Google Patents
Use of anastrozole for the treatment of post-menopausal women having early breast cancerInfo
- Publication number
- IL162150A0 IL162150A0 IL16215002A IL16215002A IL162150A0 IL 162150 A0 IL162150 A0 IL 162150A0 IL 16215002 A IL16215002 A IL 16215002A IL 16215002 A IL16215002 A IL 16215002A IL 162150 A0 IL162150 A0 IL 162150A0
- Authority
- IL
- Israel
- Prior art keywords
- breast cancer
- anastrozole
- post
- early breast
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Treatment Of Metals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0129457.8A GB0129457D0 (en) | 2001-12-10 | 2001-12-10 | Method of treatment |
PCT/GB2002/005554 WO2003053438A1 (en) | 2001-12-10 | 2002-12-06 | Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162150A0 true IL162150A0 (en) | 2005-11-20 |
Family
ID=9927290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16215002A IL162150A0 (en) | 2001-12-10 | 2002-12-06 | Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
Country Status (29)
Country | Link |
---|---|
US (1) | US20050165081A1 (xx) |
EP (2) | EP1455781B1 (xx) |
JP (2) | JP5335173B2 (xx) |
KR (1) | KR100858946B1 (xx) |
CN (1) | CN100408036C (xx) |
AT (1) | ATE406160T1 (xx) |
AU (1) | AU2002347371B2 (xx) |
BR (1) | BR0214798A (xx) |
CA (1) | CA2468965C (xx) |
CO (1) | CO5590926A2 (xx) |
CY (1) | CY1108462T1 (xx) |
DE (1) | DE60228616D1 (xx) |
DK (1) | DK1455781T3 (xx) |
ES (1) | ES2303811T3 (xx) |
GB (1) | GB0129457D0 (xx) |
HK (1) | HK1069335A1 (xx) |
HU (1) | HUP0402023A3 (xx) |
IL (1) | IL162150A0 (xx) |
IS (1) | IS7300A (xx) |
MX (1) | MXPA04005394A (xx) |
NO (1) | NO20042912L (xx) |
NZ (1) | NZ533106A (xx) |
PL (1) | PL369411A1 (xx) |
PT (1) | PT1455781E (xx) |
RU (1) | RU2320339C2 (xx) |
SI (1) | SI1455781T1 (xx) |
UA (1) | UA79443C2 (xx) |
WO (1) | WO2003053438A1 (xx) |
ZA (1) | ZA200404260B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0129457D0 (en) * | 2001-12-10 | 2002-01-30 | Astrazeneca Ab | Method of treatment |
WO2005089511A2 (en) * | 2004-03-19 | 2005-09-29 | Transform Pharmaceuticals, Inc. | Novel pharmaceutical forms, and methods of making and using the same |
WO2005117864A1 (en) * | 2004-05-28 | 2005-12-15 | Astrazeneca Ab | Combination product comprising anastrozole and a dual prenyl transferase inhibitor |
CN100337625C (zh) * | 2004-08-30 | 2007-09-19 | 鲁南制药集团股份有限公司 | 阿那曲唑的分散片剂型 |
CN1304054C (zh) * | 2004-12-29 | 2007-03-14 | 山东蓝金生物工程有限公司 | 一种缓慢释放的抗癌药物组合物 |
GB0517673D0 (en) * | 2005-08-31 | 2005-10-05 | Astrazeneca Ab | Formulation |
GB0517674D0 (en) * | 2005-08-31 | 2005-10-05 | Astrazeneca Ab | Formulation |
WO2011130381A1 (en) * | 2010-04-13 | 2011-10-20 | Estrocept Diagnostics, Inc. | Diagnostic assays for breast cancer treatment and progression |
US10201549B2 (en) | 2013-06-14 | 2019-02-12 | Professional Compounding Centers Of America (Pcca) | Testosterone combined with anastrozole injection solutions |
CN103450099B (zh) * | 2013-09-06 | 2015-03-25 | 杭州华东医药集团新药研究院有限公司 | 阿那曲唑及其一水合物的新晶型、制备和用途 |
RU2548722C1 (ru) * | 2013-12-06 | 2015-04-20 | Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" | Противоопухолевое лекарственное средство пролонгированного действия на основе противоопухолевого препарата, ингибитора синтеза эстрогенов - анастрозола |
DE102014005513B4 (de) * | 2014-04-15 | 2018-03-15 | Sanoxsys Gmbh | Mittel zur Prävention und Therapie von Tumorerkrankungen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8714013D0 (en) * | 1987-06-16 | 1987-07-22 | Ici Plc | (substituted-aralkyl)heterocyclic compounds |
AR034142A1 (es) * | 2000-09-08 | 2004-02-04 | Sloan Kettering Inst Cancer | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion |
GB0129457D0 (en) * | 2001-12-10 | 2002-01-30 | Astrazeneca Ab | Method of treatment |
-
2001
- 2001-12-10 GB GBGB0129457.8A patent/GB0129457D0/en not_active Ceased
-
2002
- 2002-06-12 UA UA20040705521A patent/UA79443C2/uk unknown
- 2002-12-06 KR KR1020047008806A patent/KR100858946B1/ko not_active IP Right Cessation
- 2002-12-06 PL PL02369411A patent/PL369411A1/xx not_active Application Discontinuation
- 2002-12-06 BR BR0214798-0A patent/BR0214798A/pt not_active Application Discontinuation
- 2002-12-06 HU HU0402023A patent/HUP0402023A3/hu not_active Application Discontinuation
- 2002-12-06 EP EP02783305A patent/EP1455781B1/en not_active Revoked
- 2002-12-06 IL IL16215002A patent/IL162150A0/xx unknown
- 2002-12-06 SI SI200230746T patent/SI1455781T1/sl unknown
- 2002-12-06 AT AT02783305T patent/ATE406160T1/de active
- 2002-12-06 DE DE60228616T patent/DE60228616D1/de not_active Expired - Lifetime
- 2002-12-06 MX MXPA04005394A patent/MXPA04005394A/es active IP Right Grant
- 2002-12-06 DK DK02783305T patent/DK1455781T3/da active
- 2002-12-06 WO PCT/GB2002/005554 patent/WO2003053438A1/en active IP Right Grant
- 2002-12-06 AU AU2002347371A patent/AU2002347371B2/en not_active Revoked
- 2002-12-06 RU RU2004121162/15A patent/RU2320339C2/ru not_active IP Right Cessation
- 2002-12-06 JP JP2003554195A patent/JP5335173B2/ja not_active Expired - Lifetime
- 2002-12-06 ES ES02783305T patent/ES2303811T3/es not_active Expired - Lifetime
- 2002-12-06 US US10/498,444 patent/US20050165081A1/en not_active Abandoned
- 2002-12-06 PT PT02783305T patent/PT1455781E/pt unknown
- 2002-12-06 CA CA2468965A patent/CA2468965C/en not_active Expired - Fee Related
- 2002-12-06 CN CNB02824544XA patent/CN100408036C/zh not_active Ceased
- 2002-12-06 EP EP08162209A patent/EP1997492A1/en not_active Withdrawn
- 2002-12-06 NZ NZ533106A patent/NZ533106A/xx not_active IP Right Cessation
-
2004
- 2004-05-31 ZA ZA2004/04260A patent/ZA200404260B/en unknown
- 2004-06-04 IS IS7300A patent/IS7300A/is unknown
- 2004-07-08 CO CO04064979A patent/CO5590926A2/es not_active Application Discontinuation
- 2004-07-09 NO NO20042912A patent/NO20042912L/no not_active Application Discontinuation
-
2005
- 2005-03-08 HK HK05101996.7A patent/HK1069335A1/xx not_active IP Right Cessation
-
2008
- 2008-10-29 CY CY20081101221T patent/CY1108462T1/el unknown
-
2010
- 2010-09-06 JP JP2010199008A patent/JP2011016828A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1069335A1 (en) | Use of anastrozole for the treatment of post-menopausal women having early breast cancer | |
MY127290A (en) | New use of flibanserin | |
HK1061354A1 (en) | Synthesis of 4-amino-thalidomide enantiomers | |
TR200201442T2 (tr) | Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı. | |
ZA200305126B (en) | Methods of administering epothilone analogs for the treatment of cancer. | |
IL159887A0 (en) | Combination therapy for the treatment of cancer | |
HK1068261A1 (en) | Combinations comprisinga selective cyclooxygenase-2 inhibitor | |
AU2003217397A8 (en) | Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer | |
MXPA04004306A (es) | Uso de antagonistas del receptor de endotelina para el tratamiento de enfermedades tumorales. | |
BR0311146A (pt) | Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo feminino | |
HK1053424A1 (en) | The use of exemestane for the preparation of a medicament for the first-line treatment of breast cancer | |
AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
SV2002000179A (es) | Proceso para la preparacion de un compuesto para reducir el riesgo del cancer ref.x-13527-el | |
MXPA01010186A (es) | Composiciones y metodos para el tratamiento y diagnostico de cancer de mama. | |
AU2002253899A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
RS16804A (xx) | Upotreba 4-piridilmetilftalazina u lečenju raka | |
AU2002365104A8 (en) | Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof | |
徐兵河 et al. | THE CLINICAL COURSE AND TREATMENT RESULTS OF LUNG METASTASES FROM BREAST CANCER | |
TW527918U (en) | Medical chest strap dedicated for breast cancer patient | |
GB0110908D0 (en) | Proreins, genes and their use for diagnosis and treatment of breast cancer | |
WO2000050022A3 (en) | Treatment regimen for hormone-sensitive cancers | |
EP1385497A4 (en) | METHOD FOR PREVENTING OR TREATING BREAST CANCER, PROSTATE AND / OR COLUMN OF UTERUS USING N, N-DIMETHYLGLYCIN | |
GB0118387D0 (en) | Proteins,genes and their use for diagnosis and treatment of breast cancer | |
NZ516564A (en) | Cancer therapy | |
ZA200108257B (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use. |